India’s domestic pharmaceutical market is estimated at $42 billion in 2021. It is likely to reach $65 billion by 2024 and further expand to $120-130 billion by 2030. Meanwhile, the Indian domestic formulations market grew at a healthy combined annual rate of 7% from 2018 to 2021.<\/p>\n\n\n\n
The domestic formulations segment is expected to grow at an annual rate of approximately 9-11% from 2020 to 2026 and demand is expected to reach \u20b92.6-2.7 trillion by fiscal 2026.<\/p>\n\n\n\n
Emcure Pharmaceuticals Limited recently filed its Draft Red Herring Prospectus with market regulator Securities and Exchange Board of India to raise funds via an initial public offering.<\/p>\n\n\n\n
The offer size is expected to be in the range of \u20b945 billion to \u20b950 billion. The IPO comprises fresh issuance of shares worth \u20b911 billion and an offer for sale of 18,168,356 shares by promoters and existing shareholders. The company is considering a pre-IPO placement aggregating up to \u20b92 billion. If that is successful, the fresh issue size will be reduced.<\/p>\n\n\n\n
Emcure plans to utilize \u20b99.47 billion from the net proceeds towards repayment or prepayment of all or a portion of certain outstanding borrowings availed by it. The remaining proceeds will be used for general corporate purposes.<\/p>\n\n\n\n
Emcure is engaged in the development, manufacturing, and marketing of a broad range of pharmaceutical products across several major therapeutic areas. It is the 12th largest pharmaceutical company in India and has a sizeable market share in gynecology and blood-related & HIV antivirals therapeutic areas.<\/p>\n\n\n\n
The Pune-based company has a differentiated product portfolio that includes orals, injectables, and biologics, as well as an mRNA platform through which its subsidiary Gennova Biopharmaceuticals is currently developing a COVID-19 vaccine. The initiative is expected to enable the company to reach a range of target markets across over 70 countries, with a strong presence in Europe and Canada.<\/p>\n\n\n\n
In fiscal 2021, Emcure had total revenue of \u20b960.91 billion, compared to \u20b951.30 billion in the previous year. The company\u2019s profit was at \u20b94.18 billion, against \u20b91.01 billion in 2020.<\/p>\n\n\n\n
While a significant portion of the company\u2019s business transactions is done in foreign currency, primarily US dollar and Euro, it reports financial results in Indian currency. Emcure also procures a noteworthy portion of raw materials from outside India and incurs costs in foreign currencies.<\/p>\n\n\n\n
External commercial borrowings and other foreign currency-denominated borrowings create foreign currency exposure in respect of cash flows and the ability to service such debt.<\/p>\n","protected":false},"excerpt":{"rendered":"
India’s domestic pharmaceutical market is estimated at $42 billion in 2021. It is likely to reach $65 billion by 2024 and further expand to $120-130 billion by 2030. Meanwhile, the Indian domestic formulations market grew at a healthy combined annual rate of 7% from 2018 to 2021. The domestic formulations segment is expected to grow […]<\/p>\n","protected":false},"author":83,"featured_media":124093,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[5747,5748,10444],"tags":[9138,1408,1115],"class_list":["post-124783","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare-stocks","category-ipo","category-others","tag-pharma","tag-pharma-stocks","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":179601,"url":"https:\/\/alphastreet.com\/india\/emcure-pharmaceuticals-q3-fy26-earnings-results\/","url_meta":{"origin":124783,"position":0},"title":"Emcure Pharmaceuticals Q3 FY26 Earnings Results","author":"Divyansh_Kasana","date":"February 5, 2026","format":false,"excerpt":"Executive Summary Emcure Pharmaceuticals Ltd reported Q3FY26 revenues of \u20b92,363 crore, up 20.38% YoY, with consolidated net profit surging 48.08% to \u20b9231 crore despite \u20b938 crore one-time labour code expenses. International sales exceeded 50% revenue mix with 24.5% growth, complemented by strong domestic chronic therapy performance. Revenue & Growth Revenues\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/E.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/E.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/E.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/E.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/E.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/E.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172833,"url":"https:\/\/alphastreet.com\/india\/emcure-q2-fy26-earnings-results\/","url_meta":{"origin":124783,"position":1},"title":"Emcure Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"December 1, 2025","format":false,"excerpt":"Emcure Pharmaceuticals Ltd , incorporated in 1981 and a global manufacturer and marketer of pharmaceutical products, reported strong financial results for Q2FY26. Financial Highlights: Revenues increased 13.39% year-on-year to \u20b92,270 crore from \u20b92,002 crore. Total expenses rose 9.52% to \u20b91,932 crore from \u20b91,764 crore. Consolidated net profit grew 24.26% to\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/E.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/E.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/E.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/E.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/E.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/E.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":125048,"url":"https:\/\/alphastreet.com\/india\/ipo-alert-wellness-forever-medicare-files-papers-for-a-public-listing\/","url_meta":{"origin":124783,"position":2},"title":"IPO Alert: Wellness Forever Medicare files papers for a public listing","author":"Nishadkishore","date":"October 20, 2021","format":false,"excerpt":"The Indian pharmaceutical industry is the world\u2019s third-largest by volume and 14th largest by value. The turnover of the country\u2019s pharmaceutical market was estimated at \u20b92.9 trillion in 2020, which is equally divided between the export and domestic markets. The domestic pharmaceutical market, which was valued at \u20b91.5 trillion last\u2026","rel":"","context":"In "Health Care"","block_context":{"text":"Health Care","link":"https:\/\/alphastreet.com\/india\/category\/healthcare-stocks\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":128249,"url":"https:\/\/alphastreet.com\/india\/ipo-alert-dharmaj-crop-guard-files-papers-for-%e2%82%b9300-crore-public-listing\/","url_meta":{"origin":124783,"position":3},"title":"IPO Alert: Dharmaj Crop Guard files papers for \u20b9300-crore public listing","author":"Nishad","date":"March 14, 2022","format":false,"excerpt":"The global pesticides market has grown at a compound annual rate of 4.3% to $67 billion in 2020 from $57 billion in 2016. It is expected to grow1.6-1.8% through 2024 and reach about $71-$72 billion. India ranks fourth in the world in agrochemicals production and 13th in pesticides exports globally.\u2026","rel":"","context":"In "Agricultural Products"","block_context":{"text":"Agricultural Products","link":"https:\/\/alphastreet.com\/india\/category\/agricultural-products\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":124111,"url":"https:\/\/alphastreet.com\/india\/ami-organics-files-ipo-worth-%e2%82%b9300-crore\/","url_meta":{"origin":124783,"position":4},"title":"Ami Organics files IPO worth \u20b9300 crore","author":"Nishadkishore","date":"July 6, 2021","format":false,"excerpt":"The pharmaceutical market in India was valued at $59 billion in 2020 and supplies over 50% globally for various vaccines. The IPOs in the pharma sector have had the most successful track record in the grey market, hence trying its luck specialty chemicals maker, Ami Organics filed preliminary papers with\u2026","rel":"","context":"In "Health Care"","block_context":{"text":"Health Care","link":"https:\/\/alphastreet.com\/india\/category\/healthcare-stocks\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":126175,"url":"https:\/\/alphastreet.com\/india\/ipo-alert-nandan-terry-is-all-set-to-go-public\/","url_meta":{"origin":124783,"position":5},"title":"IPO Alert: Nandan Terry is all set to go public","author":"Nishad","date":"December 20, 2021","format":false,"excerpt":"Global textile and apparel trade has grown at a CAGR of 4% since 2005 and has reached the level of trade at $823 billion, while the apparel industry is the most traded category with a share of 57% of total trade in T&A. Global T&A is expected to reach $1\u2026","rel":"","context":"In "IPO"","block_context":{"text":"IPO","link":"https:\/\/alphastreet.com\/india\/category\/ipo\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/07\/iStock-649278704.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/124783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/83"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=124783"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/124783\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/124093"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=124783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=124783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=124783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}